Advancements in cancer research and treatment are significantly impacting the life insurance industry, requiring agents and insurers to adapt to evolving risks and opportunities.
The Australian Medical Association (AMA) urges the federal government to enact legislation prohibiting genetic discrimination in life insurance, citing concerns about patients avoiding life-saving tests.
